Ko YH - Search Results

1

Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.

Byun JH, Lee MA, Roh SY, Shim BY, Hong SH, Ko YH, Ko SJ, Woo IS, Kang JH, Hong YS, Lee KS, Lee AW, Park GS, Lee KY. Byun JH, et al. Among authors: ko sj, ko yh. Jpn J Clin Oncol. 2006 May;36(5):263-8. doi: 10.1093/jjco/hyl024. Epub 2006 May 30. Jpn J Clin Oncol. 2006. PMID: 16735371

2

Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins.

Jung CK, Jung JH, Lee KY, Kang CS, Kim M, Ko YH, Oh CS. Jung CK, et al. Among authors: ko yh. Pathol Res Pract. 2007;203(12):839-47. doi: 10.1016/j.prp.2007.08.004. Epub 2007 Oct 29. Pathol Res Pract. 2007. PMID: 17913384

3

Docetaxel monotherapy as second-line treatment for pretreated advanced non-small cell lung cancer patients.

Ko YH, Lee MA, Hong YS, Lee KS, Park HJ, Yoo IeR, Kim YS, Kim YK, Jo KH, Wang YP, Lee KY, Kang JH. Ko YH, et al. Korean J Intern Med. 2007 Sep;22(3):178-85. doi: 10.3904/kjim.2007.22.3.178. Korean J Intern Med. 2007. PMID: 17939335 Free PMC article.

4

Prognostic factors affecting the clinical outcome of adenoid cystic carcinoma of the head and neck.

Ko YH, Lee MA, Hong YS, Lee KS, Jung CK, Kim YS, Sun DI, Kim BS, Kim MS, Kang JH. Ko YH, et al. Jpn J Clin Oncol. 2007 Nov;37(11):805-11. doi: 10.1093/jjco/hym119. Jpn J Clin Oncol. 2007. PMID: 18057012

5

Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.

Kim TH, Ko YH, Lee MA, Kim BS, Chung SR, Yoo IeR, Jung CK, Kim YS, Kim MS, Sun DI, Hong YS, Lee KS, Kang JH. Kim TH, et al. Among authors: ko yh. Cancer Res Treat. 2008 Jun;40(2):62-70. doi: 10.4143/crt.2008.40.2.62. Epub 2008 Jun 30. Cancer Res Treat. 2008. PMID: 19688050 Free PMC article.

6

Clinical significance of vascular endothelial growth factors (VEGF)-C and -D in resected non-small cell lung cancer.

Ko YH, Jung CK, Lee MA, Byun JH, Kang JH, Lee KY, Jo KH, Wang YP, Hong YS. Ko YH, et al. Cancer Res Treat. 2008 Sep;40(3):133-40. doi: 10.4143/crt.2008.40.3.133. Epub 2008 Sep 30. Cancer Res Treat. 2008. PMID: 19688120 Free PMC article.

7

Clinical characteristics of primary peritoneal carcinoma.

Roh SY, Hong SH, Ko YH, Kim TH, Lee MA, Shim BY, Byun JH, Woo IS, Kang JH, Hong YS, Lee KS. Roh SY, et al. Among authors: ko yh. Cancer Res Treat. 2007 Jun;39(2):65-8. doi: 10.4143/crt.2007.39.2.65. Epub 2007 Jun 30. Cancer Res Treat. 2007. PMID: 19746214 Free PMC article.

8

Clinical characteristics and prognostic factors for primary appendiceal carcinoma.

Ko YH, Park SH, Jung CK, Won HS, Hong SH, Park JC, Roh SY, Woo IS, Kang JH, Hong YS, Byun JH. Ko YH, et al. Asia Pac J Clin Oncol. 2010 Mar;6(1):19-27. doi: 10.1111/j.1743-7563.2010.01276.x. Asia Pac J Clin Oncol. 2010. PMID: 20398034

9

Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.

Ko YH, Roh SY, Won HS, Jeon EK, Hong SH, Lee MA, Kang JH, Hong YS, Kim MS, Jung CK. Ko YH, et al. Head Neck Oncol. 2010 Oct 30;2:30. doi: 10.1186/1758-3284-2-30. Head Neck Oncol. 2010. PMID: 21034499 Free PMC article.

10

Pancreatic endocrine tumors: a report on a patient treated with sorafenib.

Jeong HK, Roh SY, Hong SH, Won HS, Jeon EK, Shin OR, Lee SL, Ko YH. Jeong HK, et al. Among authors: ko yh. J Korean Med Sci. 2011 Jul;26(7):954-8. doi: 10.3346/jkms.2011.26.7.954. Epub 2011 Jun 20. J Korean Med Sci. 2011. PMID: 21738352 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,061 results

Search Page

Filters